16-372208-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_021259.3(PGAP6):c.2095G>A(p.Val699Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000422 in 1,611,006 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_021259.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PGAP6 | NM_021259.3 | c.2095G>A | p.Val699Ile | missense_variant | 13/13 | ENST00000431232.7 | NP_067082.2 | |
PGAP6 | XM_047434413.1 | c.1516G>A | p.Val506Ile | missense_variant | 14/14 | XP_047290369.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PGAP6 | ENST00000431232.7 | c.2095G>A | p.Val699Ile | missense_variant | 13/13 | 1 | NM_021259.3 | ENSP00000401338.2 | ||
PGAP6 | ENST00000250930.7 | c.1516G>A | p.Val506Ile | missense_variant | 13/13 | 2 | ENSP00000250930.3 | |||
PGAP6 | ENST00000424078.5 | c.496G>A | p.Val166Ile | missense_variant | 4/4 | 3 | ENSP00000397620.1 |
Frequencies
GnomAD3 genomes AF: 0.0000398 AC: 6AN: 150634Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000124 AC: 31AN: 249518Hom.: 0 AF XY: 0.0000960 AC XY: 13AN XY: 135450
GnomAD4 exome AF: 0.0000425 AC: 62AN: 1460372Hom.: 0 Cov.: 31 AF XY: 0.0000399 AC XY: 29AN XY: 726460
GnomAD4 genome AF: 0.0000398 AC: 6AN: 150634Hom.: 0 Cov.: 32 AF XY: 0.0000544 AC XY: 4AN XY: 73506
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at